HomeUSGI Medical Inc.

USGI Medical Inc.

USGI Medical Receives FDA Approval to Expand US Pilot Study Evaluating Incisionless Weight Loss Procedure – POSE 2.0

The non-invasive, endoscopic procedure, known as POSE 2.0, is designed to evaluate weight loss for adults suffering from obesity with a body mass index of 35 to 40 kg/m and an obesity-related comorbidity, such as diabetes or hypertension.